Introduction {#S1}
============

Selective intercellular adhesion and cell-cell communication are key mechanisms for the proper development of organisms. Cell adhesion is mediated by different types of transmembrane molecules, of which the most prominent are the cadherins ([@B93]). These are calcium-dependent cell adhesion proteins, a characteristic that led their discoverer, Masatoshi Takeichi, to coin in 1988 their name as a portmanteau of "calcium adherens" ([@B237]). The cadherin superfamily comprises several subfamilies, including the classical cadherins (type I and type II), desmosomal cadherins, protocadherins, flamingo/CELSR and cadherin related proteins, that all contain multiple cadherin motifs within their extracellular domain ([@B100]).

In this review, we will exclusively focus on protocadherins (Pcdhs). Several excellent reviews have covered the diverse roles that Pcdhs play in development ([@B205]; [@B273]; [@B86]; [@B144]; [@B174]) and disease ([@B107]; [@B91]; [@B113]; [@B47]; [@B192]). Nevertheless, the way Pcdh engagement translates cell-cell interaction information in these different contexts to the cell remains elusive. After briefly describing the discovery, the characteristics, and the main roles of these Pcdhs, this review covers recent structural studies, molecular processing and downstream signaling in the context of cancer and neurodevelopment.

History and General Characteristics of Pcdhs {#S1.SS1}
--------------------------------------------

The discovery of Pcdhs dates back to 1993, when several novel cadherin-like sequences were identified in a variety of organisms. Sano et al. described these molecules as similar to cadherins, but containing six or seven instead of five cadherin repeats in their ectodomain, as well as a transmembrane domain and a peculiar cytoplasmic tail. Indeed, the latter did neither show homology to the typical cadherin cytoplasmic tail nor complete conservation between different Pcdhs ([@B214]). Since the novel molecules somewhat resembled the Drosophila cell-adhesion protein Fat, Sano et al. suggested that the identified cadherin repeats could be derived from one primordial cadherin sequence, thus named the new molecules "protocadherins" ([@B214]). Comparing the evolutionary conservation of different Pcdhs, Hulpiau and van Roy suggested that they derived from an ancestral FAT-like cadherin by stepwise loss of extracellular cadherin (EC) repeats ([@B100]).

After being found to be expressed predominantly in mouse neural tissues and neuroblastoma cell lines, Pcdhs were independently discovered in 1998 as Cadherin-related neuronal receptors (CNRs) ([@B120]). Their expression at synaptic complexes suggested a possible role in establishing synaptic connections. CNRs were found to be encoded by clusters of tandemly arrayed genes and became known as clustered Pcdhs (cPcdhs). Furthermore, as cells expressed different combinations of a set of CNR variable exons, Kohmura et al. suggested that these molecules might form hetero-multimers that could equip cells with thousands of unique recognition modules ([@B120]). One year later, Wu and Maniatis found numerous additional CNR-like molecules encoded by tandemly arranged gene arrays, which were organized as three clusters (α, β, and γ) on human chromosome 5q31 ([@B267]). Due to their similarities to PCDH2 ([@B214]), they were included in the Pcdh family and subdivided according to their cluster in α-, β-, and γ-Pcdhs (Pcdh-α, Pcdh-β, Pcdh-γ) ([@B267]). Further sequence alignments and protein analyses revealed that these cPcdhs consist of a variable extracellular domain (ECD), a transmembrane domain (TM), and an intracellular domain (ICD) ([@B267]). For all three gene clusters, the ECD, the TM and a short part of the ICD are encoded by one large variable exon, a short part of the ICD are encoded by one large variable exon, while remainder of the ICD is encoded by three constant exons that are shared within a cluster ([@B268]) ([Figure 1](#F1){ref-type="fig"}). Within the α- and γ-Pcdh clusters, the variable exons region can be further subdivided into alternate exons and C-type exons. Alternate exons can be classified into A- and B-type exons within the γ-Pcdh cluster. C-type exons are more similar to each other than to those encoding alternate isoforms within the same cluster, and generate α-Pcdhs C-isoforms C1 and C2, and γ-Pcdhs isoforms C3, C4, and C5 ([@B267]; [@B269]; [@B260]). The β-Pcdh cluster lacks the constant exons and therefore encodes proteins with a truncated intracellular domain ([Figure 2](#F2){ref-type="fig"}).

![Schematic depiction of cPcdh gene organization to molecular structure. Both variable exons and constant exons encode cPcdhs. Variable exons are located upstream of constant exons for each cluster and are further categorized into alternate exons and C-type exons. The three constant exons in the α- and γ-Pcdh loci encode the common part of the respective ICDs. The β-Pcdh gene cluster does not encode C-isoforms nor presents constant exons, and therefore all related molecules lack the common ICD. Within the γ-Pcdh cluster alternate exons can be further subdivided into A- and B-type exons. After stochastic promoter choice and *cis* splicing, one variable exon encodes the extracellular domain (ECD), the transmembrane domain (TM), and part of the intracellular domain (ICD) of one Pcdh isoform. C-type exons encode C-isoforms.](fnmol-13-00117-g001){#F1}

![Molecular structure of Protocadherin family members. cPcdhs: α-, β-, and γ-Pcdhs present 6 extracellular cadherin (EC) repeats (ellipses) in their extracellular domain (ECD), a transmembrane domain (TM), and a conserved intracellular domain (ICD) (with the exception of β-Pcdhs, which possess a truncated ICD). The variable cytoplasmic domain (VCD) motif has been observed in some γ-Pcdhs and α-Pcdhs. ncPcdhs (δ0-Pcdhs, δ1-Pcdhs, and δ2-Pcdhs) represent transmembrane proteins with either 7 (for δ0-Pcdhs, δ1-Pcdhs) or 6 (for δ2-Pcdhs) EC repeats. Within their ICDs, δ1-Pcdhs have three conserved motifs (CM), while δ2-Pcdhs have two CMs. Moreover, δ2- and a few α-Pcdhs harbor a WAVE interacting receptor sequence (WIRS).](fnmol-13-00117-g002){#F2}

cPcdhs are generally conserved across vertebrate species, although the β-Pcdh cluster is missing in fugu, zebrafish and *Xenopus*, and the number of variable exons is not constant ([@B267]; [@B269]; [@B287]; [@B51]).

At the time of their discovery, it was known that cPcdhs were not the only Pcdh subfamily members. Indeed, a number of *Pcdh* genes had been found to be scattered throughout the genome ([@B59]; [@B205]; [@B252]). The largest group of these non-clustered Pcdh (ncPcdh), the δ-Protocadherins (δ-Pcdhs), was identified via phylogenetic analysis. δ-Pcdhs can be further subdivided into δ 0-, δ1- and δ2-type based on their mutual homology and the number of ECD cadherin repeats (respectively, 7 and 6) ([@B252]; [@B100]). Pcdh20 is the only δ0-Pcdh member ([@B100]). Members of the δ1-Pcdh subfamily include Pcdh1, Pcdh7, Pcdh9, and Pcdh11-X/-Y; members of the δ2-Pcdh subfamily are Pcdh8, Pcdh10, Pcdh17, Pcdh18 and Pcdh19 ([@B214]; [@B229]; [@B94]; [@B284]; [@B12]; [@B188]; [@B268]; [@B265]). δ-Pcdhs can have several isoforms, which contain identical extracellular domains, but differ in their cytoplasmic domain ([@B118]). While δ2-Pcdhs have two conserved motifs, CM1 and CM2, in their intracellular domain ([@B265]), δ1-Pcdhs have an additional conserved motif (CM3) containing a putative binding site for protein phosphatase-1α (PP1α) ([@B252]). Peculiarly, these conserved motifs are absent in other ncPcdhs: Pcdh12 and Pcdh20. Still, Pcdh20 has been classified as a δ0-Pcdh due to the strong homology of its 7 ECD to δ1-Pcdhs ([@B100]; [@B118]; [@B99]).

Formerly, cadherin-related (Cdhr) proteins were considered as either Pcdhs or cadherins, although they have a distinct molecular structure and have evolved differently from both. They are related to cadherins as they present (at least two) consecutive EC repeats in their ECD. Some known misnomer examples are Pcdh15, Pcdh16, and μ-Pcdh. Based on additional comparative genomic analyses across metazoan organisms evolution they were later named Cdhr15, Cdhr6, and Cdhr5, respectively ([@B100]; [@B99]; [@B72]).

Expression and Roles of Pcdhs {#S2}
=============================

Several ncPcdhs and cPcdhs are expressed most prominently within the central nervous system ([@B252]; [@B204]; [@B118]; [@B90]), which suggests important neurobiological roles for these molecules. On the other hand, loss of Pcdhs has been linked to several cancer types. In this section we summarize expression modalities of Pcdhs and, in relation to them, describe their roles in the nervous system and in cancer.

Clustered Pcdhs in the Nervous System {#S2.SS1}
-------------------------------------

### Combinatorial Expression of cPcdh Isoforms Generates Cell Surface Diversity and Specificity {#S2.SS1.SSS1}

Expression studies of γ-Pcdh isoforms across subgroups (PcdhγA, PcdhγB, and PcdhγC) show generally overlapping patterns in large brain areas. While broader regions can express similar subsets of *Pcdhα* and *Pcdh*γ, alternative promoter selection and pre-mRNA *cis* splicing are used to generate specific combinations of different isoforms within individual cells ([@B238]; [@B260]).

Single cell RT-PCR analysis of Purkinje cells has revealed that most isoforms of these cPcdhs are monoallelically and combinatorially expressed in single neurons, whereas all five C-type isoforms are expressed biallelically and uniformly in all of these neurons ([@B50]; [@B110]; [@B92]). In contrast, C-type isoforms have been only found in a small percentage of mouse olfactory sensory neurons (OSN). Interestingly, immature OSN still express alternate and C-type isoforms, suggesting downregulation of C-type isoforms throughout their maturation ([@B175]). Studies performed on serotonergic neurons revealed an exclusive expression of Pcdh C-isoforms in these cells, with PcdhαC2 being the most prominently expressed ([@B31]; [@B112]).

Isoform expression thus seems to be cell type specific, and bound to complex regulatory mechanisms. CPcdhs expression level and specificity are also epigenetically regulated. Each variable exon contains a specific promoter that is regulated by its position within the cluster ([@B185]; [@B109]), the orientation of enhancer elements ([@B74]) and the DNA methylation status ([@B73]). Epigenetic regulation of promoter choice and alternative transcripts therefore immensely increases the diversity of cPcdhs that can be generated. For additional detailed information on the epigenetic regulation of *Pcdh*-α and *Pcdh-*γ gene expression we refer to recent excellent reviews ([@B47]; [@B174]; [@B21]).

Collectively, these studies indicate that transcriptional regulation can generate a large cell-surface molecular diversity and specificity within single neurons, creating functional diversification ([@B50]; [@B110]; [@B92]; [@B31]; [@B112]; [@B175]). However, not all neuronal cell types express multiple cPcdhs, and expression can be dynamic during development. More careful mapping of expression at the single-cell level would reveal whether expression patterns are stochastic within certain cell populations or not.

### Roles in Development of Dendrites and Synapses {#S2.SS1.SSS2}

Various members of all three Pcdh clusters localize on the neuronal soma, on dendrites and axons, and at growth cones and synapses in differentiating and mature neurons ([@B120]; [@B260]; [@B108]; [@B197]; [@B106]).

In the context of dendrite development, cPcdhs play important roles in dendritic self-avoidance. γ-Pcdh isoform diversity is essential for the discrimination between isoneural and heteroneural dendrites in retinal starburst amacrine cells (SAC)s, as loss of this diversity impairs dendritic self-avoidance ([@B132]; [@B121]). In the cerebral cortex, γ-Pcdhs promote dendritic arborization complexity in layer V pyramidal neurons ([@B65]). Recently it was shown that α- and γ-Pcdhs can functionally interact and cooperate in dendritic development in a context-dependent manner, and that together they mediate dendrite self-avoidance in Purkinje cells ([@B102]).

cPcdhs are also implicated in spine morphogenesis. γ-Pcdhs negatively regulate mouse cortical dendritic spine morphogenesis *in vivo* ([@B170]). In contrast, deletion or knockdown of the γ-Pcdh cluster has been associated with a reduction in spine density and dendritic complexity in mouse olfactory granule cells and cultured hippocampal neurons ([@B234]; [@B131]). CA1 pyramidal neurons and cultured hippocampal neurons of *Pcdha* null mutant mice display simple arbors and low dendritic spine densities. Knockdown of γ-Pcdhs and knockout of α-Pcdhs *in vitro* leads to similar defects as in *Pcdha* null mutant mice, suggesting that both γ- and α-Pcdh members contribute to dendritic arborization ([@B234]).

Although functional evidence is still lacking, the molecular diversity and isoform-specific homophilic binding properties of cPcdhs might provide a synaptic adhesive code to support synaptogenesis and proper neural connectivity ([@B120]; [@B221]; [@B222]). α-Pcdhs are found in neocortical synapses ([@B120]) and in perisynaptic sites of preganglionic terminals in chicken ([@B13]). In mouse hippocampal neurons overexpression of a dominant-negative α-Pcdh ICD leads to a reduction in spine number and decrease of presynaptic synaptophysin ([@B234]). Whether α-Pcdh isoforms are involved in synaptic adhesion ([@B120]) as has been shown for γ-Pcdhs ([@B66]) remains to be elucidated. β-Pcdhs accumulate dendritically and post-synaptically in mammalian retinal and cerebellar neurons, suggesting a potential involvement of β-Pcdhs in synaptogenesis and synaptic refinement ([@B106]; [@B202]).

γ-Pcdhs are found in synaptic intracellular compartments such as axonal and dendritic tubulovesicular structures within some hippocampal neurons ([@B197]; [@B57]). PcdhγC5 is localized in a subset of GABAergic and glutamatergic synapses in cultured hippocampal neurons, majorly at dendrites as shown by colocalization of PcdhγC5 with specific synaptic proteins such as GABAergic presynaptic glutamate decarboxylase and vesicular glutamate transporter 1 ([@B139]). In addition, it has been shown that PcdhγC5 is important for the stabilization and maintenance of some GABAergic synapses, but not for their formation ([@B140]). γ-Pcdhs were shown as well to play a role in synaptic elimination between closely spaced SACs, and in preventing autapse formation. Functional connectivity was impaired in neighboring SACs expressing a single γ-Pcdh isoform, demonstrating a necessary function of isoform diversity in establishing inter-SAC networks ([@B121]). In conclusion, several lines of evidence point to γ-Pcdhs as key molecular players in synapse formation, stabilization and maintenance in the mammalian nervous system. Unfortunately, current knowledge is limited to particular cPcdhs and specific neuronal cell types, hence studies focusing on different neuronal types or α and β clusters in this context might be revealing in the future. However, even for γ-Pcdhs exact roles in the regulation of synaptic function remain to be defined, and are likely to be context-dependent.

### Roles in Axonal Development, Targeting and Branch Repulsion {#S2.SS1.SSS3}

cPcdhs participate in several aspects of axonal development, and their potential to generate unique molecular codes are at the basis of both axon-target and axon-axon recognition mechanisms.

α-Pcdhs are indispensable for axon growth in cultured hippocampal neurons ([@B155]). Whether this role is unique to this cluster remains to be investigated. In the mouse spinal cord, loss of γ-Pcdhs leads to severe disorganization of Ia primary afferent projection terminals in the ventral horn, leading to a targeting defect between Ia afferents and ventral horn interneurons that suggests a critical role of γ-Pcdh-mediated recognition between the two ([@B200]; [@B84]).

Other studies have revealed functions in axon targeting and branch repulsion which appear to be redundantly shared by all cPcdhs. Deletion of all three clusters, but not of single clusters, leads to the complete disruption of axonal arborization and to clumping of axonal terminals in mouse OSN. Overriding Pcdh diversity through overexpression of a fixed set of 3 cPcdhs (one α-, one β-, and one γ-Pcdh) in OSN results in the failure of axon terminals to converge and form normal glomeruli. In this case, the induced expression of an identical cPcdh membrane code seems to result in the erroneous self-avoidance between non-self axons ([@B175]).

In sharp contrast to what has been observed in the development of OSN connectivity, axonal tiling of serotonergic neurons is highly dependent on a single cPcdh isoform, PcdhαC2, that drives repulsion between neurites of distinct cells and ensures proper spatial axon distribution ([@B31]; [@B112]). To what extent other specific cPcdh isoforms have unique roles in the arrangement and targeting of projections between specific subpopulations of neuronal cells remains to be addressed.

### Roles in Neuronal Survival {#S2.SS1.SSS4}

Members of the γ-Pcdh cluster are known to prevent neuronal apoptosis of spinal cord interneurons, retinal cells, and cortical interneurons (cINs) ([@B261]; [@B133]; [@B199]; [@B30]; [@B65]; [@B84], [@B83]; [@B22]; [@B134]). Transplantation studies and knockout mice phenotyping showed that loss of C-type γ-Pcdhs leads to increased cell death in spinal cord interneurons and cINs ([@B30]; [@B134]). Remarkably, within the C-type γ-Pcdhs, only one isoform (PcdhγC4) seems to be necessary for neuronal survival of several cell populations ([@B64]).

While γ-Pcdhs appear to be particularly important in mouse neuronal survival, in zebrafish truncation of an α-Pcdh, Pcdh1α, has been found to lead to neuronal cell death in the developing brain and spinal cord ([@B49]).

Different cPcdh clusters can also cooperate in the regulation of cell death and survival. For instance, the α-Pcdh and γ-Pcdh clusters have been demonstrated to cooperatively regulate neuronal survival in the retina ([@B102]). In the spinal cord, interneuron apoptosis is aggravated in βγ-Pcdh and αβγ-Pcdh deficient mice compared to mice lacking only γ-Pcdhs, suggesting this process to be cPcdh dosage-dependent ([@B84]). Moreover, cPcdhs seem to cooperate to prevent apoptosis in a cell type-specific manner. In chimeric mice lacking all three clusters (αβγ-Pcdh deficient mice), survival rates were found to significantly decrease in neuronal populations in the midbrain, pons and medulla, but not in the inferior olive, in sensory and motor neurons, and neuronal populations within the cerebral cortex and olfactory bulb ([@B261]; [@B84], [@B83]). Therefore, context-specific combinatorial expression of cPcdhs appears to be important in the regulation of neurodevelopmental cell death versus survival.

Non-clustered Pcdhs in the Nervous System {#S2.SS2}
-----------------------------------------

### Combinatorial Expression of ncPcdhs Contributes to Specification of Neuronal Identity {#S2.SS2.SSS1}

Similarly to classical cadherins, ncPcdh expression is spatiotemporally regulated during brain development in several vertebrate species. In zebrafish and chicken, this mode of expression characterizes transcription of *Pcdh9, Pcdh17*, and *Pcdh19* in the nervous system ([@B152], [@B151]; [@B90]; [@B147]). In the mouse brain, *Pcdh7*, *Pcdh9* and *Pcdh11* expression localizes to restricted regions within the neocortex, hippocampus and amygdala ([@B252]). In rat, *Pcdh1*, *Pcdh9*, *Pcdh10*, *Pcdh17*, *Pcdh19*, and *Pcdh20* are specifically expressed in limbic system structures, such as the hippocampus, the limbic cortex, the thalamus, the hypothalamus, and the amygdala. Cortical region-dependent and layer-specific expression can also be observed perinatally ([@B117]). In addition, Pcdh10 synthesis has been described in specific networks like the limbic and visual systems in mice and chicken ([@B94]; [@B3]; [@B177]).

Besides being present in distinct brain areas, δ-Pcdhs have been demonstrated to be combinatorially expressed in the ferret retina and in the mouse primary sensory cortex ([@B52]; [@B127]). Moreover, it was recently shown that one mouse OSN can express up to seven δ-Pcdhs, and that cells can adjust the number and expression levels of δ-Pcdhs on their surface to regulate their adhesivity ([@B9]).

Overall, the combinatorial and molecule-specific spatiotemporal expression patterns of ncPcdhs in the vertebrate central nervous system point at roles in neural circuit formation, potentially by contributing to a molecular recognition code.

### Roles in Synaptic, Dendritic, and Axonal Development {#S2.SS2.SSS2}

Like cPcdhs, δ-Pcdhs are localized in dendrites, axons, and proximally to or within synapses ([@B94]; [@B277]; [@B96]; [@B190]). All members of the δ1-Pcdh family and the majority of the δ2-Pcdh family, with the exception of Pcdh18, have been associated to the regulation of dendritic initiation, growth, morphology, arbor refinement, and spine formation ([@B277]; [@B198]; [@B18]; [@B266]; [@B217]; [@B6]; [@B24]). To date, roles in axon growth, branching, guidance, and fasciculation have been described for Pcdh7 and for almost all of the δ2-Pcdhs except Pcdh8 ([@B3]; [@B247]; [@B178]; [@B198]; [@B137], [@B136]; [@B10]; [@B85]; [@B40]; [@B4]; [@B71]). While specific synaptic roles have not yet been directly demonstrated for δ1-Pcdhs, they have been suggested to participate in synaptic maintenance and plasticity based on their expression at synapses and interaction with PP1α ([@B284]; [@B252]; [@B117]; [@B18]). Roles in synaptogenesis, synaptic vesicle assembly and mobility, synapse elimination, and synaptic connectivity have been demonstrated for all δ2-Pcdhs ([@B277]; [@B245]; [@B96]; [@B10]; [@B6]; [@B145]; [@B157]). While the role of cPcdhs in neuronal self-avoidance has been extensively described (see sections above), nearly no information is available for ncPcdhs in this context. Interestingly, removal of the Pcdh17 cytoplasmic domain in zebrafish has been shown to induce axon clumping in somatic motor neurons, but not in spinal interneurons, pointing to cell-type specific roles in fasciculation and guidance/targeting via ncPcdh-mediated homotypic repulsion ([@B4]). [Table 1](#T1){ref-type="table"} summarizes currently known roles of ncPcdhs in synapse, dendrite, and axon development.

###### 

Different roles of ncPcdhs in dendritogenesis, axon development and synaptogenesis.

  ------------------------------
  ![](fnmol-13-00117-t001.jpg)
  ------------------------------

Roles of Pcdhs in Cancer {#S2.SS3}
------------------------

In addition to the expression of Pcdhs during (brain) development, several tissues maintain expression of these molecules at adult stages. While research into their exact function at these stages is still in its infancy, they might regulate cellular differentiation, tissue regeneration and maintenance. Best studied in this regard is *PCDH1* in lung epithelial cells ([@B55], [@B56]; [@B122]). Consequently, dysregulation of *PCDH* expression has been extensively associated with multiple types of cancer. This reflects the wider-scale relationship between oncogenesis and cadherin-mediated cell adhesion, as members from other cadherin subfamilies are known to be involved in tumor suppression or progression (reviewed in detail by [@B251]. While most *PCDH* genes are considered tumor suppressors, multiple exceptions have been observed.

The epigenetic mechanisms governing the expression of *cPCDHs* and their unique genomic organization render them sensitive to long range epigenetic silencing (LRES). Indeed, agglomerative hypermethylation of all three or individual *cPCDH* clusters has been identified in breast cancer, cervical cancer, colorectal cancers, uterine leiomyosarcoma and leiomyoma, and in Wilms' tumor ([@B186]; [@B43], [@B44]; [@B168]; [@B259]). Moreover, a vast array of studies has identified individual *PCDH* downregulation due to promoter hypermethylation or somatic aberrations (see [Table 2](#T2){ref-type="table"}). The most frequently reported phenotypes resulting from loss of *PCDH* expression are increased proliferation and decreased apoptosis; however, considering that these processes are the most commonly investigated in cancer, it is likely that additional loss of function effects have been understudied. Several signaling pathways have been linked to the regulation of proliferation (Wnt/β-catenin signaling and Pi3K/AKT-signaling) and apoptosis (NF-κB and DEPDC1-caspase signaling) by PCDHs in cancer ([@B97]; [@B143]; [@B29]; [@B156]; [@B272]; [@B276]; [@B278]; [@B298]). Less commonly reported consequences of *PCDH* loss include increased migration/invasion, epithelial--mesenchymal transition, angiogenesis, and resistance to drugs. The signaling pathways that PCDHs utilize to regulate these processes are still poorly understood ([@B141]; [@B297]; [@B29]; [@B156]). Loss of *PCDH* expression in cancer is often an indicator of poor prognosis, either directly as a result of metastasis, or indirectly through increased resistance to drugs and apoptosis (see references [Table 2](#T2){ref-type="table"}). Overall, downregulation of all classes of *PCDHs* in somatic cells has been associated with cancer malignancy, supporting a role in the control of cell survival, proliferation, and migration.

###### 

Downregulation of Pcdh genes in cancer due to somatic aberrations (SA) or promoter hypermethylation (PH).

  Organ                               reg.   PCDH gene   References             
  ----------------------------------- ------ ----------- ---------------------- ---------------------------------------------
  Bladder                             PH     *c*         *GA12*                 [@B206]
                                             nc          *8, 7, 17*             [@B42]; [@B148]; [@B262]
  Blood                               PH     c           *GA12, GB7*            [@B225]; [@B239]
                                             nc          *8, 10, 17*            [@B281]; [@B135]; [@B179]; [@B141]; [@B250]
  Brain                               PH     *c*         *A8, A13, GC4, GA11*   [@B256]; [@B1]; [@B291]
                                      both   nc          *10*                   [@B8]
                                      SA     nc          *8, 9*                 
  Breast                              PH     *c*         *GB6, B15*             [@B167]; [@B288]
                                             nc          *1, 10, 17*            [@B167]; [@B253]; [@B280]
                                      both   nc          *8*                    [@B286]
  Cervix and ovary                    PH     nc          *10*                   [@B180]
                                      SA     nc          *9*                    [@B224]
  Colon and rectum                    PH     c           *B3, GA7*              [@B279]; [@B153]
                                             nc          *10, 17, 18*           [@B97]; [@B294]; [@B295]
  Esophagus, hypo-, and nasopharynx   PH     nc          *8, 17, 20*            [@B67]; [@B87]; [@B29]
                                      both   nc          *10*                   [@B282]
  Kidney                              PH     c           *B5*                   [@B270]
                                             nc          *8*                    [@B173]
  Liver                               PH     nc          *10, 19*               [@B282]; [@B54]; [@B290]
                                      both   nc          *9*                    
                                      SA     nc          *17, 20*               [@B156]; [@B45]
  Lung                                PH     c           *GB6*                  [@B150]
                                             nc          *10, 17, 20*           [@B101]; [@B282]; [@B248]
  Muscle                              PH     c           *A4*                   [@B243]
  Pancreas                            PH     c           *GA6, GB1, GB6*        [@B255]
                                             nc          *1, 8, 10, 11Y*        [@B255]; [@B203]
                                      both   c           *GC4*                  [@B104]; [@B255]
                                             nc          *17*                   [@B104]; [@B255]
                                      SA     c           *B2, B16, GA1, GA11*   [@B104]
                                             nc          *9,18*                 [@B104]
  Prostate and Testicle               PH     nc          *10, 17*               [@B142]; [@B149]
  Stomach                             PH     nc          *8, 10*                [@B285]; [@B289]
                                      both   nc          *17*                   [@B97]; [@B111]
                                      SA     c           *B1, GA9*              [@B111]; [@B264]
                                             nc          *7*                    [@B26]

The clustered (c) and non-clustered (nc) PCDHs are grouped.

In contrast, some studies have correlated hypomethylation leading to ectopic expression of specific *PCDHs* with cancer progression, suggesting context-specific roles for these molecules. Examples include *PCDHB9* in gastric cancer, *PCDHGC5* in astrocytomas, and *PCDH11Y* in prostate cancer ([@B275]; [@B176]; [@B254]). The mechanisms via which ectopic *PCDH* expression results in cancer progression are insufficiently investigated, however, pathological outcomes (e.g., metastasis, increased chance of relapse, drug resistance) are comparable to those observed with loss of *PCDH* expression as described above ([@B275]; [@B176]; [@B254]). Intriguingly, expression of *PCDH7* and *PCDH10*, which are generally considered to be tumor suppressor genes, has been proven necessary for the tumorigenicity of non-small cell lung cancer and glioblastoma, respectively ([@B46]; [@B296]). PCDH7 induces MAPK signaling in non-small cell lung cancer, and its expression is associated with poor prognosis ([@B296]). Moreover, it has been hypothesized that *PCDH11Y* expression might occur downstream of Relaxin, and its increase could drive neuroendocrine transdifferentiation by activating the Wnt signaling pathway ([@B275]; [@B240]).

Taken together, it is clear that dysregulation of Pcdh expression is extensively linked to tumor progression. However, while several roles of Pcdhs in neuronal development have been mechanistically dissected, most oncological studies have focused on the characterization of PCDHs as potential biomarkers. The molecular processes they mediate in cancer therefore remain mostly unknown. In general, PCDHs seem to regulate cancer cell proliferation, migration and/or apoptosis. Interestingly, individual PCDH functions seem to be context-dependent, as some PCDHs can be considered both tumor suppressors or proto-oncogenes according to the type of cancer examined.

Structural Aspects of Pcdh Interactions {#S3}
=======================================

To fulfill different roles in neural circuit development and cancer, Pcdhs engage in unique interactions with other cadherin motif-containing molecules. According to the classical view, Pcdhs interact homophilically in *trans* (apposing cell membranes) via their extracellular cadherin motifs. Binding in *trans* has been studied using cell aggregation assays in K562 cells. These cells are non-adherent, lack endogenous expression of Pcdhs, and provide an ideal system to study the effect of Pcdh expression on adhesion behavior in cell aggregation assays. These assays have been used to obtain qualitative readouts of *trans* interactions and to quantitatively measure binding affinity, and have allowed the discrimination between different adhesion levels and co-aggregation patterns ([@B218]; [@B241]; [@B212]; [@B9]). Combined results from X-ray crystallography, bioinformatic modeling, cell aggregation assays, and evolutionary correlations have further revealed that *trans* homophilic interfaces are formed between specific cadherin repeats.

Besides homophilic *trans* binding, cell aggregation assays, solution biophysical measurements and X-ray crystallography have shown that cPcdhs can engage in homotypic and heterotypic dimers on the same cell membrane via *cis* interactions, expanding the array of unique cell surface protein identities ([@B218]; [@B241]; [@B213]; [@B69]). Similar *cis* interactions through the extracellular domains have not been found for ncPcdhs ([@B81]), but it cannot be excluded that other domains (transmembrane or intracellular) mediate *cis* interactions between these Pcdh members.

Both *trans* and *cis* interactions thus confer unique features (adhesion and cell surface "barcoding", respectively), to Pcdh-expressing cells, which might explain how less than 100 isoforms create the necessary variety for self-recognition and neuronal wiring.

*Trans* Interactions {#S3.SS1}
--------------------

### Clustered Pcdhs {#S3.SS1.SSS1}

Pcdhs interactions differ significantly from those occurring between classical cadherins. Pcdhs are only partially dependent on calcium for *trans* binding ([@B218]); moreover, cPcdhs lack a hydrophobic pocket and have fewer glycosylation sites ([@B172]; [@B218]; [@B241]; [@B183]; [@B213]). Analyses on γ-Pcdhs first identified the EC2 and EC3 domains (with EC1 being the most N-terminal cadherin domain) as those mediating specificity in homophilic *trans* interactions between Pcdhs ([@B218]; [@B241]). Among cPcdhs, only PcdhαC1 was found to not conform to the homophilic adhesion rule, likely due to the absence of a calcium binding motif in EC3 which might affect its structure ([@B241]).

*Trans* homophilic interfaces are formed via EC1--EC4 antiparallel domain interactions in a head-to-tail orientation, allowing binding of EC1 with EC4, and EC2 with EC3 ([@B183]). Single-domain mismatches between either EC4 and EC1 or EC2 and EC3 were shown to be sufficient in, respectively, blocking *trans* dimerization or preventing co-aggregation ([@B213]).

Several studies examining the Pcdh adhesive interface furthermore revealed that both its conformation and the interaction preferences of interface-localized residues are necessary for Pcdh binding specificity ([@B183], [@B184]; [@B41]; [@B69], [@B70]; [@B17]). *Trans* interaction specificity is mediated by the EC1--EC4 interface, whereas the EC2--EC3 interface contributes to a greater extent to *trans* interaction affinity ([@B70]; [@B182]) ([Figure 3](#F3){ref-type="fig"}).

![Depiction of hypothetical cPcdh-, ncPcdh-, and classical cadherin-mediated interactions between cell membranes. **(A)** cPcdhs interact to form a zipper-like array consisting of matching *cis* homo- or heteromultimers on opposed surfaces, associating in *trans* via homophilic monomer binding. **(B)** δ1-Pcdhs form *trans* homodimers and weaker *trans* heterodimers. δ2-Pcdhs also form *trans* homodimers, and might further associate with classical cadherins (e.g., N-cad), potentially through the transmembrane domain. Whether ncPcdh interact in *cis* through the transmembrane or intracellular domain is unknown.](fnmol-13-00117-g003){#F3}

Non-clustered Pcdhs {#S3.SS2}
-------------------

δ-PCDH are also characterized by homophilic interactions in *trans* ([@B96]; [@B9]; [@B81]). Structurally, the *trans-*dimers formed by cPcdhs and δ2-Pcdhs were proven to be quite similar. Indeed, X-ray crystallography analyses revealed that two zebrafish Pcdh19 molecules on adjacent cells interact via a "forearm handshake" involving EC1--EC4 domain binding ([@B41]), and that human PCDH1 proteins also homophilically dimerize in an antiparallel manner through these domains ([@B169]). Cell/bead aggregation studies using Pcdh7 EC1-4 or Pcdh9 single deletion mutants demonstrated that EC1--EC4 and EC2--EC3 interactions seem to confer, respectively, dimer binding affinity and binding specificity ([@B9]; [@B193]).

Moreover, aggregation assays performed on K562 cells showed that, like for cPcdhs, the combinatorial expression of δ-Pcdhs supports self-recognition; thus, cells presenting identical δ-Pcdhs surface combinations aggregate, while cells expressing different δ-Pcdhs segregate. These coaggregation experiments also revealed that combination mismatches lead to three aggregation types ("intermixing", "interfacing", and "segregating") defined by a high, medium, or low number of shared cell boundaries, respectively. Furthermore, centrifugation-based aggregation assays indicated that different δ-Pcdhs have distinct adhesive affinities. These characteristics, as well as the relative surface expression of diverse δ-Pcdhs, determine the overall cell adhesive activity, which is ultimately reflected in a particular co-aggregation behavior ([@B9]). Interestingly, intermediate aggregation modes with incomplete Pcdh surface repertoire matching have been only reported so far for δ-Pcdhs. In line with this evidence, weak *trans* heterophilic interactions have been shown to occur within the subfamilies of human δ1- and δ2-Pcdhs, although these seem subtype-specific and more prevalent between different δ1-Pcdhs rather than δ2-Pcdhs ([Figure 3](#F3){ref-type="fig"}) ([@B81]).

*Cis* Interactions {#S3.SS3}
------------------

### Clustered Pcdhs {#S3.SS3.SSS1}

*Cis* interactions between cPcdhs are mediated via the extracellular domain and, in contrast to *trans* associations, are highly promiscuous between distinct members of the α-, β-, and γ-Pcdh clusters ([@B79]; [@B215]; [@B218]; [@B241]; [@B213]). These interactions also ensure proper delivery of α-Pcdh isoforms to the cell surface, as *cis* binding with β- and/or γ-Pcdh through the EC6 domain is crucial in this context ([@B241]; [@B213]).

Additionally, cPcdhs *cis* multimerization allows the establishment of new homophilic specificities in *trans* ([@B218]; [@B70]). *Cis* multimers can form independently of *trans* interactions through EC6 domains with an affinity comparable to EC1--EC4-mediated *trans* binding ([@B213]). One recent study described the crystal structure of a PcdhγB7 *cis* homodimer as a model for *cis* cPcdh interactions. This analysis demonstrated that interfacing occurs asymmetrically between EC5 and EC6 domains of one molecule and the EC6 domain of the other, and suggested that cPcdh surface expression requires dimerization. As α-Pcdhs cannot dimerize, they can only provide the EC5-6 side of the dimer interface. This likely explains why α-Pcdhs necessitate heterodimerization with a carrier Pcdh for cell surface delivery ([@B68]).

### Non-clustered Pcdhs {#S3.SS3.SSS2}

Evidence for inter-ncPcdhs *cis* binding came first from studies on *Xenopus* paraxial protocadherin (PAPC/Pcdh8). PAPC molecules were shown to form *cis* homodimers via ECD-located cysteine residues, and these interactions were proven to be essential for proper PAPC trafficking, maturation, and function ([@B33]). Pcdh19 interactions in homo- or heterodimers were also demonstrated via K562 cell assays, and *cis* binding disruption was suggested to underlie the developmental abnormalities characterizing epilepsy and intellectual disability linked to females (EFMR) ([@B191]). However, recent structural evidence obtained from the investigation of δ-Pcdhs in solution was not able to substantiate any ECD-mediated *cis* interactions. Moreover, no conservation of *cis-*interface motifs characterizing cPcdh ECDs was found in δ-Pcdhs, thereby ruling out cPcdh-like *cis-*interactions through the ECD for δ-Pcdhs ([@B81]). The observed *cis* interactions between Pcdh19 with other δ2-Pcdhs in K562 cells might therefore rely on transmembrane or ICD interactions ([Figure 3](#F3){ref-type="fig"}).

Clustered Pcdh Zipper Arrays Orchestrate Cell--Cell Interactions {#S3.SS4}
----------------------------------------------------------------

*Cis* associations across cPcdhs can generate structural elements necessary for *trans* Pcdh binding, which contributes to neuronal self versus non-self discrimination. Depending on the context, the interplay of these interactions can lead to cell--cell adhesion or repulsion.

Several lines of evidence including computational modeling, cell aggregation, X-ray crystallography, and cryo-electron tomography data indicate that cPcdhs establish one-dimensional zipper-like structures by simultaneously engaging in *cis* and *trans* interactions. These complexes emerge when a cPcdh *cis* dimer binds two other dimers in trans, thereby forming a lattice unit; multiple units can then linearly assemble in long arrays to bring together adjacent cell surfaces ([@B213]; [@B68]; [@B17]) ([Figure 3A](#F3){ref-type="fig"}). According to this interaction mechanism model, known as the "isoform mismatch chain termination" model, one isoform mismatch within the zipper assembly is sufficient to stop the linear propagation of lattice units, and therefore impair contact-induced repulsion. Thus, this model explains how differential expression and surface display of 58 cPcdhs can sustain the molecular diversity required for neuronal barcoding, self/non-self discrimination, and self-avoidance ([@B213], [@B212]).

Recent evidence indicated that formation of adhesive zipper-like complexes by ncPcdhs is less likely to occur. In solution, δ-Pcdhs have been observed to generate dimers, but not oligomers. Moreover, conserved key residues required for *cis* interaction in cPcdhs ([@B70], [@B68]) were found to be missing in δ-Pcdhs. In addition, when δ-Pcdhs ECDs were attached to liposomes to visualize intermembrane adhesion, high concentrations of *trans* dimers were observed between membranes. However, the typical ordered-lattice periodicity previously observed for cPcdhs ([@B17]) was in this case absent ([@B81]).

An Overarching Interaction Model Involving Classical Cadherins and ncPcdhs {#S3.SS5}
--------------------------------------------------------------------------

Aggregation experiments showed that K562 cells co-expressing *Pcdh7* and *Pcdhb11* either segregate or interface with *Pcdhb11*-positive cells according to the ratio of expression between the two Pcdhs. The fact that ncPcdhs can modulate the aggregation strength of cPcdhs suggested the formation of heteromeric Pcdh complexes that mediate cell recognition ([@B9]). Although recent structural studies did not observe any cross-family interactions between cPcdhs and δ-Pcdhs, the surface plasmon resonance binding studies used extracellular EC1-4 and might have missed *cis* interactions occurring through other domains ([@B81]). Hence, whether fine tuning of adhesion versus repulsion via Pcdh dosage regulation observed in cells coexpressing Pcdh7 and Pcdhb11 involves *cis* interactions between these Pcdhs remains to be studied.

Adhesive properties of Pcdh are also affected by classical cadherins, and some ncPcdhs were demonstrated to bind in *cis* with these molecules, although the exact domains required for these interactions remain unknown. The *Xenopus* Pcdh8 paralog PAPC is able to regulate the adhesion activity of the classical cadherin C-cad; however, whether this function is mediated by direct *cis* binding has yet to be proven ([@B32]). In cultured rat hippocampal neurons, the *cis* association between Pcdh8 and N-cadherin (N-cad, Cdh2) through the transmembrane domain regulates N-cad endocytosis. In addition, cadherin 11 (Cdh11) was also found to associate with Pcdh8 ([@B277]). Moreover, genetic dissection of neural progenitor patterning in zebrafish indicates the reliance of this process on an adhesive code formed by N-cad, Cdh11, and Pcdh19 ([@B246]). In zebrafish, N-cad and Pcdh19 or Pcdh17 interact in cis, potentially also through the transmembrane domain. In this case, the mediator of homophilic interactions is likely to be Pcdh19, whereas N-cadherin might be required as a *cis-*cofactor to achieve Pcdh-mediated cell adhesion ([@B11]; [@B48]).

Evidence supporting *cis* interactions between classical cadherins and cPcdhs is currently scarce. Overexpression of cPcdhs and N-cad in K562 cells was shown to result in strong aggregation mediated by *trans* homophilic binding involving either cPcdh or N-cad molecules, and provided no evidence of *cis* interactions between these groups ([@B241]). However, one co-immunoprecipitation study has revealed that γ-Pcdhs can associate with R-cadherin (Cdh4) and N-cad, suggesting that these particular interactions might occur in specific contexts ([@B79]).

[Figure 3](#F3){ref-type="fig"} synthesizes our current knowledge on Pcdh-mediated *trans* and *cis* interactions. [Figure 3A](#F3){ref-type="fig"} depicts the zipper array model of cPcdh interaction ([@B17]) combined with promiscuous *cis* associations between clusters ([@B218]; [@B241]; [@B68]). The recently described *trans* homophilic and subfamily, dependent heterophilic binding dynamics between δ-Pcdhs ([@B81]) are illustrated in [Figure 3B](#F3){ref-type="fig"} together with the putative interaction of δ2-Pcdhs with N-cad. Considering all available evidence regarding the association between ncPcdhs and classical cadherins, it can be hypothesized that ncPcdhs might contact classical cadherins in a context-dependent manner ([Figure 3B](#F3){ref-type="fig"}). Indeed, other cadherin members such as Cdh11 could participate in such a complex through interaction with N-cad ([@B246]).

How these interactions translate to specific Pcdh-associated functions is still a matter of debate. The regulation of self-avoidance by cPcdhs has been attributed to extracellular contact-mediated repulsion. While the "isoform mismatch chain termination" model relates mismatches to smaller homophilic interaction interfaces ([@B213]), this model might seem counterintuitive, as larger adhesive *trans* interactions are linked to repulsion instead of adhesion. What precisely triggers the repulsive signaling downstream of zipper-like cPcdh array formation is unknown. Besides, it is also still unclear how δ-Pcdh signaling might induce repulsion, as observed in abducens motor neurons. In this case, expression of Pcdh17 lacking its ICD caused axonal clumping, indicating that the ICD transduces the repellent signal ([@B4]).

In the traditional view, homophilic *trans* interaction involving cadherins, including Pcdhs, results in adhesion, which is supported by the observation that interaction with classical cadherins strengthens the adhesive character ([@B246]). Intriguingly, cPcdh homophilic binding could translate to adhesion for specific cell types as well, as reducing cell-surface Pcdh repertoire diversity to one γ-Pcdh isoform in cortical neurons appears to stabilize matching and disrupt non-matching neuron--neuron and neuron--astrocyte contacts *in vitro* and *in vivo*, resulting in enhanced or reduced dendritic arborization, respectively ([@B171]). In conclusion, the consequences of Pcdh-mediated interactions from a cell adhesion perspective seem highly dependent on the cellular (specific cell type) and molecular (Pcdh type and subdomain characteristics) context. The elucidation of the molecular mechanisms downstream of Pcdh interaction therefore represents an important and exciting research avenue for future studies.

Signaling Downstream of Pcdhs {#S4}
=============================

Pcdhs interact with a range of molecules to regulate diverse downstream signaling pathways. The following sections will discuss molecular subdomains of Pcdhs mediating these interactions, their known intracellular partners, and downstream signaling pathways, emphasizing the link between different molecular networks and specific Pcdh-associated functions.

The Pcdh Cytoplasmic Tail {#S4.SS1}
-------------------------

The ICD of Pcdhs is known to play a crucial role in the activation of downstream signaling cascades including Wnt, WAVE, apoptotic, and trafficking pathways. While some of these signaling events depend on the cooperative action of multiple Pcdhs, others seem to be unique to specific Pcdhs. The α-Pcdh constant exons generate three alternative splice isoforms with either a short (B-isoform), a long (A-isoform), or no (O-isoform) ICDs ([@B232]). These diverse cytoplasmic domains seem to have distinct functions, as mice with downregulated or truncated A-isoforms show abnormalities in fear conditioning and spatial working memory, whereas no phenotype can be observed in mice lacking the B-isoform ([@B60]). Within the γ-Pcdh cluster, PcdhγC3, which possesses a shorter cytoplasmic tail, is the sole isoform able to interact with and inhibit Axin1, a Wnt pathway activator ([@B267]; [@B160]).

The cytoplasmic domains of the δ-Pcdhs differ from those of the cPcdhs and are subject to alternative splicing, which creates a larger molecular diversity in ncPcdh ICDs. Intra-exonic splicing was observed for several δ-Pcdh genes ([@B267]; [@B205]; [@B252]). Alternative splicing of *Pcdh8* mRNA leads to the production of two isoforms differentially expressed in the nervous system ([@B162]). In the embryonic mouse brain, isoforms with variable cytoplasmic tail lengths have been reported for Pcdh1, Pcdh7, and Pcdh11X ([@B214]; [@B283]; [@B284]; [@B117]; [@B204]). Specific roles have been attributed to domains within the ICD; for instance, studies have shown that the CM2 domain of Pcdh7 mediates apoptosis in mouse primary cortical neurons, and that only the short isoform of rat Pcdh8 can induce N-cad endocytosis ([@B277]; [@B271]).

Several ICD interacting proteins known to be associated with a range of signaling pathways have been identified for all types of Pcdhs (for an overview and references see [Table 3](#T3){ref-type="table"}). Elucidating the structures of all ICDs, their molecular interactors, and the associated downstream pathways is essential to understand the diverse functions of different Pcdhs.

###### 

Known cytoplasmic domain interactors of Pcdhs.

  Pcdh   Pathway/role           Interactor    References
  ------ ---------------------- ------------- --------------------------
  α      WAVE                   FAK           [@B27]
                                Pyk2          
                                WAVE          [@B25]
  γ      WAVE                   FAK           [@B27]
                                Pyk2          
                                PKC           [@B114]
         WNT                    Axin1         [@B160]
         GABA                   γ2-GABA~A~R   [@B140]
         Apoptosis              PDCD10        [@B146]
         Calcium signaling      CAMKP         [@B189]
  δ1     Synaptic plasticity    PP1α          [@B284]; [@B252]
         Differentiation        Taf1          [@B88]
         TGF-β                  Smad3         [@B55]
  δ2     WAVE                   Nap1          [@B178]; [@B236]; [@B10]
                                Cyfip2        [@B236]
                                WAVE          [@B25]
         WNT                    C2kβ          [@B116]
                                Nlk1          [@B128]
         GABA                   α1-GABA~A~R   [@B6]
         Migration              Dab1          [@B95]
         Neurosteroids          NONO          [@B195]
         Synaptic endocytosis   TAO2β         [@B277]

Proteolytic Processing of Pcdhs as a Potential Signaling Mechanism {#S4.SS2}
------------------------------------------------------------------

Proteolytic processing is an important transduction mechanism for type I classical cadherins, such as N-cad and epithelial cadherin ([@B163]; [@B164]; [@B208]; [@B235]; [@B103]; [@B38]). ICD cleavage and subsequent nuclear translocation might also be a general characteristic of Pcdh-dependent signaling, as multiple studies have shown nuclear ICD localization for several Pcdhs (e.g., PcdhγC3, PcdhγC5, Pcdhα4, and Pcdh1α). Here, we present a brief overview of the different steps involved in the proteolytic processing and intracellular transport of the Pcdh ICD which may mediate specific Pcdh functions ([Figure 4](#F4){ref-type="fig"}).

![Pcdh proteolytic processing. **(A)** The proteolysis of Pcdhs and the potential translocation of their ICDs can be described as a three-step process. First, shedding by MMPs (e.g., ADAM10) releases the ECD, leaving a transmembrane C-terminal fragment (CTF1). Second, CTF1 is then cleaved by γ-secretase at the TM level to produce a soluble fragment, CTF2. Third, CTF2 (i.e., the ICD) interacts with cytoplasmic proteins and can be degraded or translocated to the nucleus, where it might participate in regulating gene expression. **(B)** cPcdhs interact at the membrane creating a zipper array characterized by alternate *cis-trans* binding. This stable complex might prevent proteolysis by making domains targeted by MMPs and γ-secretases inaccessible.](fnmol-13-00117-g004){#F4}

### Shedding {#S4.SS2.SSS1}

Ectodomain shedding, whereby the ECD is cleaved by matrix metalloproteinases (MMPs) such as disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) ([Figure 4](#F4){ref-type="fig"}), was described for cPcdhs (PcdhγC3 and Pcdhα4) and ncPcdhs (Pcdh12) ([@B207]; [@B20]; [@B15]). Additionally, shedding of PcdhγC3 and Pcdh12 was shown to be regulated by, among others, calcium-dependent and protein kinase C-mediated pathways ([@B207]; [@B15]). Endocytosis prior to shedding is required for Pcdhα4, as blocking of endocytosis prevented shedding ([@B20]). PcdhγC3 ECD shedding by ADAM10 can be increased through the activation of glutamate receptors via α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) stimulation, suggesting that neuronal activity can too regulate shedding. Furthermore, PcdhγC3 ECD shedding could be involved in the regulation of cell adhesion, as its inhibition increases cell aggregation ([@B207]).

### Cleavage {#S4.SS2.SSS2}

Pcdh ICD cleavage occurs at the TM level subsequently to shedding, and is mediated by the γ-secretase complex via its catalytic component presenilin ([@B207]; [@B20]) ([Figure 4A](#F4){ref-type="fig"}). This process might be regulated by *cis* and *trans* interactions between Pcdhs. For instance, the formation of cPcdh zipper arrays at the cell membrane could impede proteolysis by ADAM10 and γ-secretase ([Figure 4B](#F4){ref-type="fig"}) ([@B78]; [@B17]). The progressive reduction of Pcdh cleavage during neuronal differentiation, which comprises a gradual increase in Pcdh--Pcdh interactions, supports this hypothesis ([@B20]).

### Nuclear Translocation {#S4.SS2.SSS3}

After release by cleavage, the ICD can translocate to the nucleus to regulate gene expression, be intracellularly trafficked within the endosomal system, or be degraded by the proteasome ([@B197]; [@B75]; [@B57]; [@B80]; [@B15]; [@B187]; [@B226]) ([Figure 4A](#F4){ref-type="fig"}). While nuclear localization was substantiated for γ- and α-Pcdhs ([@B75]; [@B14]; [@B49]), the target genes or nuclear interactions of Pcdh ICDs are so far poorly characterized.

Regarding γ-Pcdhs, Ca^2+^/calmodulin-dependent protein kinase phosphatase (CaMPK) was shown to bind to PcdhγC5 and inhibit the nuclear translocation of the PcdhγC5 ICD. Once in the nucleus, the γ-Pcdh ICD was suggested to mediate autoregulatory γ-Pcdh expression processes by binding to the γ-Pcdh locus ([@B78]).

Among ncPcdhs, the ICD of human Pcdh FAT1 was found to translocate to the nucleus owing to a juxta-membrane nuclear translocation signal (NLS) ([@B159]). Moreover, the PCDH19 ICD, which contains several predicted NLSs, was shown to nuclearly localize and interact with the nuclear paraspeckle protein NONO in human cell lines ([@B195]).

### Endosomal/Lysosomal Trafficking {#S4.SS2.SSS4}

Studies have shown that Pcdhs can be found in presynaptic and postsynaptic endosomal vesicles. Pcdhs can also regulate intracellular trafficking of synapse-associated proteins. For instance, Pcdh8 was demonstrated to associate with N-cad and induce its endocytosis at synapses, while Pcdh10 was shown to mediate associations between PSD-95 and the proteasome to initiate PSD-95 degradation ([@B277]; [@B245]; [@B23]).

In the case of cPcdhs, evidence highlights the importance of the ICD for endosomal trafficking. For instance, the ICD of α-Pcdhs was found to interact with the endosomal sorting complex required for transport (ESCRT) in undifferentiated neuronal cells ([@B20]). Moreover, the ICD of γ-Pcdhs was demonstrated to be required for intracellular trafficking and cell surface delivery of these Pcdhs, and a conserved 26--residue ICD segment, known as the variable cytoplasmic domain (VCD) motif, was proven to be crucial for endolysosomal targeting ([@B57], [@B58]; [@B187]; [@B226]). Furthermore, it was shown that colocalization of γ-PcdhA and γ-PcdhB isoforms with the endolysosomal markers autophagy protein LC3 and lysosome associated membrane protein 2 (LAMP-2) are ICD-dependent ([@B20]; [@B80]). Initially, Pcdhs that do not engage in *trans* binding at the synaptic membrane were postulated to be endocytosed and stored in intracellular organelles to be eventually recycled ([@B197]; [@B105]; [@B58]). Later, cPcdh trafficking was speculated to be involved in self-avoidance. According to the latter hypothesis, cPcdh-mediated matching between cell surfaces might induce endolysosomal trafficking of adhesive molecules, leading to the transition from transmembrane adhesion to detachment ([@B196]; [@B129]).

WAVE Regulatory Complex (WRC) Signaling {#S4.SS3}
---------------------------------------

The actin cytoskeleton is dynamically remodeled during neurobiological processes such as neuronal migration, axon outgrowth and function, and dendritic spine formation and plasticity ([@B165]; [@B115]; [@B227]). Actin cytoskeletal dynamics are regulated by the WAVE regulatory complex (WRC), a heteropentameric complex consisting of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 (WAVE1), cytoplasmic FMR1-interacting protein 1 (CYFIP1), Nck-associated protein (Nap1), Abelson-interacting protein 2 (Abi2) and hematopoietic stem/cell progenitor protein 300 (HSPC300); orthologs of these proteins can also function as substitute components. The WRC acts on the cytoskeleton by controlling Arp2/3 complex-mediated actin assembly ([@B35]). Several cPcdhs and ncPcdhs are involved in the activation of the WRC, which in turn stimulates the formation of F-actin ([@B178]; [@B27]; [@B236]; [@B65]; [@B234]; [@B10]; [@B85]; [@B53]) ([Figure 5](#F5){ref-type="fig"}).

![Pcdh interactions with cell adhesion kinases and the WRC. cPcdhs can regulate the WRC complex by inhibiting autophosphorylation of both tyrosine kinase Pyk2 and focal adhesion kinase FAK. In the absence of γ-Pcdhs, FAK activates by autophosphorylation and phosphorylates protein kinase C (PKC). PKC phosphorylates myristoylated alanine rich protein kinase C substrate (MARCKS), which displaces MARCKS from the cell membrane and thus impairs their actin binding activity. In the presence of cPcdhs, inactive Pyk2 cannot inhibit Rac1 phosphorylation. Subsequently, Rac1 GTPase binds the WRC complex and triggers actin polymerization via the Arp2/3 complex. cPcdhs and ncPcdhs can as well directly recruit WRC components. For instance, δ2-Pcdhs can bind to Nap1, activating GTPases that positively regulate Arp2/3-driven actin polymerization.](fnmol-13-00117-g005){#F5}

### cPcdhs Inhibit Cell Adhesion Kinases, and Can Recruit WRC Proteins {#S4.SS3.SSS1}

cPcdhs can regulate the activity of cytoskeletal regulators such as Pyk2, focal adhesion kinase (FAK), and Rho-GTPases (e.g., Rac1) in processes such as dendritic arborization (α-, γ-Pcdhs) and cortical neuron migration (α-Pcdhs) by binding through their cytoplasmic tails ([Figure 5](#F5){ref-type="fig"}). This binding inhibits the kinase activity, thus resulting in the activation of Rho GTPases capable of modulating neuronal cytoskeletal reorganization via both WRC- and non-WRC-mediated mechanisms ([@B27]; [@B65]; [@B234]; [@B53]).

In γ-Pcdh-deficient mice defective dendritic arborization is the result of elevated phosphorylation of myristoylated alanine rich protein kinase C substrate (MARCKS). In the absence of γ-Pcdhs, FAK is activated through autophosphorylation. FAK in turn phosphorylates and activates protein kinase C (PKC) and phospholipase C (PLC). Active PKC phosphorylates MARCKS, leading to its dissociation from the membrane and actin ([@B82]), and consequently to a decrease in arbor complexity ([@B65]). Additionally, PKC can contribute to the negative regulation of dendritic arborization by phosphorylating the ICD of γ-Pcdhs and allowing FAK release ([@B114]).

The ICD of α-Pcdhs was found to not only regulate dendritic morphology, but also to control cortical radial migration by inhibiting the autophosphorylation of Pyk2, and by recruiting the WRC via its WAVE interacting receptor sequence (WIRS) ([@B27]; [@B65]; [@B234]; [@B53]). This WIRS motif is present and highly conserved in several other Pcdhs, including Pcdh10, Pcdh17, Pcdh18b, and Pcdh19 ([@B25]). Aberrant dendritic development and spine morphogenesis have also been connected to loss of α-Pcdhs. When α-Pcdhs are present, Pyk2 autophosphorylation is prevented, thus Rac1 is phosphorylated and activates the WRC; ultimately, this influences the formation of lamellipodial and filopodial protrusions ([@B27]; [@B65]; [@B234]; [@B53]).

### ncPcdhs Recruit Nap1 and Other WRC Components {#S4.SS3.SSS2}

Nap1 is a core component of the WAVE complex and an important actin regulator ([@B35]). Several δ2-Pcdh ICDs (10, 17, 18b and 19) bind Nap1 through a conserved binding site, enabling δ2-Pcdh to regulate actin dynamics ([@B178]; [@B236]; [@B10]; [@B85]).

The interaction of δ2-Pcdhs with Nap1 plays a role in axon development. In deletion models, defects in axon initiation, outgrowth, pathfinding and branching have been reported in zebrafish motor neurons, mouse striatal axons, and *Xenopus* retinal ganglion cells (RGCs) ([@B247]; [@B178]; [@B198]; [@B10]). The influence of these interactions on growth cone dynamics are exemplified by Pcdh17-expressing amygdala neuronal projections. Pcdh17 ICD can associate with Nap1, WAVE1 and Abi1, and recruit the WRC at inter-axonal contact sites. Additionally, Pcdh17 can recruit Lamellipodin (LPD)/MIG10 and Ena/VASP proteins via Nap1 to these sites, facilitating growth cone migration along other axons and thereby supporting collective axon extension. The GTPase Rac seems to be necessary for the recruitment of Nap1 by Pcdh17 ICD, as Rac inhibition blocks Nap1 and VASP agglomeration at contact sites ([@B85]). Rac is proposed to bind and regulate LPD interaction with the WRC and recruit Ena/VASP proteins to facilitate actin filament elongation ([@B201]; [@B130]; [@B125]).

NcPcdh interactions with the WRC can also regulate cell migration processes. For instance, the Pcdh10 ICD can recruit Nap1 and WAVE1 to cell-cell contacts, and was shown to stimulate cell migration in human astrocytoma cells via F-actin and N-cad reorganization at contact sites ([@B178]).

Thus, while cPcdhs facilitate Rho GTPases-mediated cytoskeletal reorganization principally by inhibiting cell adhesion kinases, ncPcdhs directly bind WRC components, which then promotes actin polymerization through actin regulators ([Figure 5](#F5){ref-type="fig"}).

Synaptic Regulatory Pathways {#S4.SS4}
----------------------------

Pcdh8 is implicated in the control of dendritic spine density. Upon *cis* binding of Pcdh8 to N-cad, Pcdh8 ICD activates the MAP kinase (MAPK) TAO2β. This in turn activates MEK3 which then phosphorylates p38. p38 feedback signaling on TAO2β results in the synaptic endocytosis of N-cad and Pcdh8. Through this pathway, Pcdh8 was shown to downregulate the number of dendritic spines in rat hippocampal neurons ([@B277]) ([Figure 6A](#F6){ref-type="fig"}).

![Pcdh dendritic spine and synaptic regulatory pathways. **(A)** Upon *cis* binding of Pcdh8 to Ncad, MAPK (TAO2β) is activated. A phosphorylation cascade subsequently activates MEK3 and p38. P38 phosphorylates TAO2β which results in synaptic endocytosis of Pcdh8/Ncad *cis* complex. **(B)** Pcdh10 acts downstream of MEF2 which initiates the transcription of MDM2. Once MDM2 ubiquitinates PSD-95. Pcdh10 can bind to the latter binds and associates it to the proteasome leading to synapse elimination. **(C)** γ-Pcdhs negatively regulate dendritic spine density by inhibiting the binding of Neuroligin1 (NLg1) to Neurexin1β. **(D)** The ICDs of Pcdh19 and PcdhγC5 interact, respectively, with GABA~*A*~ receptor (GABA~*A*~R) subunits α1 and γ2, respectively, and stabilize the membrane expression of the GABA~*A*~R subunits.](fnmol-13-00117-g006){#F6}

Pcdh10 appears necessary for synapse elimination in the central nervous system. In cultured cortical and hippocampal neurons, Pcdh10 was found to act downstream of the transcription factor MEF2 to associate ubiquitinated PSD-95 with the proteasome ([@B245]) ([Figure 6B](#F6){ref-type="fig"}).

As mentioned above, binding of α-Pcdh ICD to Pyk2 positively regulates spine morphogenesis ([@B234]). γ-Pcdhs instead negatively regulate cortical spine morphogenesis via *cis* interaction with Neuroligin-1 (Nlg1). This binding was shown to block the interaction of Nlg1 with Neurexin1β, thus inhibiting the Nlg1-mediated presynaptic differentiation and promotion of dendritic spine density in cultured cortical neurons ([@B170]). In contrast, another study provided evidence for positive synaptogenesis regulation by γ-Pcdhs. However, this analysis was performed in spinal cord interneurons and in combination with astrocytes, which might have contributed to synaptogenesis through Pcdh-mediated homophilic binding ([@B66]) ([Figure 6C](#F6){ref-type="fig"}).

PcdhγC5 and Pcdh19 ICD interact in *cis* with GABA~*A*~ receptor (GABA~*A*~R) subunits γ2 and α1, respectively. Both Pcdhs regulate membrane expression of the GABA~*A*~R subunits, possibly by facilitating their trafficking to the cell surface ([@B140]; [@B6]) ([Figure 6D](#F6){ref-type="fig"}). Recently, a model for Alzheimer's Disease (AD) was postulated whereby PcdhγC5 could increase inhibitory neurotransmission by enhancing synaptic GABAergic signaling and thus counterbalance the hyperexcitation caused by β-amyloid plaques ([@B138]). Taken together, these findings suggest the involvement of several Pcdhs in synaptic transmission, although their specific action mechanisms in this context remain to be further examined.

Apoptotic Pathways {#S4.SS5}
------------------

### Protocadherins as Antagonists of Oncogenic Proliferation {#S4.SS5.SSS1}

*PCDH10* is a tumor suppressor gene that reduces cell proliferation in hepatocellular carcinoma (HCC), and can induce cancer cell apoptosis via several routes. First, PCDH10 can negatively regulate the PI3K/Akt signaling pathway, resulting in tumor suppressor gene 53 (p53) degradation ([@B292]; [@B278]). Second, PCDH10 can induce apoptosis by inhibiting the NF-κB pathway, thus reducing anti-apoptotic proteins such as B-cell lymphoma (Bcl)-2 and survivin ([@B143]). PCDH10 expression blocks NF-κB phosphorylation and nuclear translocation via IκB kinase (IKK) inhibition, hence preventing NF-κB constitutive activation. Third, PCDH10 can directly activate caspases to trigger apoptosis ([@B143]; [@B276]).

Furthermore, PCDH9 was shown to act as a tumor suppressor by eliciting apoptosis and G0/G1 cell cycle arrest in glioma cells. In these cells, PCDH9 expression, respectively, upregulated and downregulated the synthesis of BAX and BCL-2 ([@B258]). Similarly, in gastric cancer cells *PCDHGA9* overexpression induced apoptosis, cell cycle arrest, and autophagy. In this case, PCDHGA9 blocked TGF-β-induced epithelial-mesenchymal-transition (EMT) by inhibiting SMAD2/3 phosphorylation and nuclear translocation ([@B264]). In colorectal cancer restoring PCDH17 expression was found to enhance apoptotic pathway activation, and to induce autophagy by upregulating autophagic proteins such as Atg-5 and LC3BII ([@B97]).

In conclusion, current evidence suggests that several Pcdhs mediate pro-apoptotic functions through different signaling pathways.

### Dosage of Pcdhs in Relation to Apoptosis in the Brain {#S4.SS5.SSS2}

In the developing brain both loss and overexpression of Pcdhs can elicit neuronal apoptosis. Therefore, the maintenance of proper Pcdh levels is crucial to preserve the balance between neuronal death and survival.

Excessive Pcdh7 causes primary cortical neuron apoptosis via downregulation of the apoptotic inhibitor survivin (BIRC5), and effect that is mediated by the cytoplasmic CM2 domain of Pcdh7 ([@B271]).

Contrarily, in the absence of γ-Pcdhs Pyk2 autophosphorylates and accumulates in the cells, triggering their death ([@B27]). In addition, the γ-Pcdh ICD interacts with the intracellular adaptor protein programmed cell death 10 (PDCD10), and PDCD10 depletion attenuates chicken spinal neuron apoptosis caused by knockdown of γ-Pcdhs, implicating PDCD10 as an inducer of apoptosis downstream of these cPcdhs. In this context, γ-Pcdhs might protect neurons from apoptosis by sequestering PCDC10. Moreover, PDCD10 and Pyk2 cooperate to mediate the γ-Pcdhs-induced neuronal apoptosis ([@B146]).

Recently, γ-Pcdhs-deficient cINs were shown to have reduced phosphorylated serine-threonine kinase (AKT) levels. Numerous anti-apoptotic/pro-survival actions have been attributed to the PI3K-AKT pathway ([@B19]), and cytoplasmic phospho-AKT is known to act as an anti-apoptotic factor. As loss of γ-Pcdhs increased apoptosis in cINs, γ-Pcdhs appear to have a role in cIN survival mediated by AKT ([@B22]).

Overall, regulating Pcdh surface expression appears to be important for neuronal survival. Neuronal apoptosis is induced by ncPcdh overexpression or cPcdh loss. In oncogenesis, most Pcdhs seem to have a tumor suppressor function, as for several cancer types their downregulation \[with the exception of PCDHB9 ([@B176]; [@B220]), and PCDH9 ([@B210])\] correlates with tumor survival. Taken together, the precise dosage control of Pcdhs might therefore be crucial for cell survival in different contexts.

Wnt Canonical and Non-canonical Signaling {#S4.SS6}
-----------------------------------------

Wnt signaling is a powerful regulator of cell proliferation and differentiation, and is crucially involved in cell fate determination, cellular migration, cellular polarity, organ morphogenesis, and correct tissue patterning during embryonic development ([@B154]; [@B119]; [@B158]; [@B194]; [@B37]; [@B219]; [@B63]; [@B228]). Pcdhs have been mostly linked to canonical β-catenin-dependent, but also to non-canonical Wnt signaling.

### The Relation Between Pcdh and Wnt β-catenin Signaling {#S4.SS6.SSS1}

Over the last decade, evidence suggestive of a functional relationship between the Wnt signaling pathway and Pcdhs has been collected from a variety of studies. Intriguingly, the effect of Pcdh expression on Wnt signaling seems to be Pcdh- and context-dependent. The relationship between the Wnt pathway and Pcdhs has been mostly examined in cancer, where loss of Pcdhs often increases Wnt signaling, which in its turn stimulates cellular proliferation. A comprehensive overview of the different ways Pcdhs can regulate canonical Wnt signaling is shown in [Figure 7](#F7){ref-type="fig"}.

![Regulation of Wnt signaling by Pcdhs. **(A)** Sequestration of Wnt signaling molecules. Left: β-catenin sequestration. Similar to classical cadherins, some Pcdhs contain a β-catenin binding site that allows retention of this molecule at the plasma membrane. A direct binding site has been identified in Pcdh7, while α- and β-catenin have been shown to co-immunoprecipitate with Pcdhγ. Whether binding occurs directly or indirectly via a common binding partner in this case is currently unknown (question mark). Sequestration results in decreased translocation of β-catenin to the nucleus, thereby reducing transcription of Wnt target molecules. Right: Axin sequestration. PcdhγC3 can directly sequester Axin, thereby competing with Disheveled (Dvl). In the absence of PcdhγC3, binding of Wnt ligands to Frizzled receptors recruits Dvl, which in turn recruits Axin. Axin can bind several kinases, including Gsk3β and Ck1γ, which activate Lrp6 by phosphorylation and inhibits β-catenin degradation. Binding of Axin to PcdhγC3 inhibits Lrp6 phosphorylation, hence indirectly stimulating cytoplasmic β-catenin degradation, and reducing transcription of Wnt target genes. **(B)** Regulation of key phosphorylation events. Overexpression of Pcdh8, Pcdh10, Pcdh18, and Pcdh20 results in an increase of active (non-phosphorylated) Gsk3β. Active Gsk3β within the destruction complex (Axin, APC, CK1a and Gsk3β) phosphorylates β-catenin, resulting in its ubiquitination and degradation by the proteasome. The mechanism through which Pcdhs regulate Gsk3β phosphorylation has yet to be characterized. **(C)** Indirect activation or strengthening of Wnt signaling via transactivators. Pcdh10 has been shown to reduce the expression of Bcl9, a β-catenin transcriptional cofactor. The Bcl9-Pygopus protein complex allows β-catenin nuclear targeting, leading to its interaction with Tcf/Lef transcription factors and ultimately the expression of Wnt target genes.](fnmol-13-00117-g007){#F7}

Pcdhs appear to affect canonical Wnt signaling primarily by changing the ratio of nuclear versus cytoplasmic β-catenin. The subcellular distribution of β-catenin can be regulated at different levels. Reported mechanisms include: (1) the retention of β-catenin at the nucleus, the cytoplasm, or the plasma membrane; (2) the degradation of β-catenin in the cytoplasm by the destruction complex; (3) the independent or guided nuclear import/export of β-catenin, for example via TCF4 and BCL9 (import) or APC and Axin1 (export) ([@B7]; [@B98]; [@B89]; [@B181]; [@B211]; [@B242]; [@B124]; [@B39]; [@B244]; [@B126]).

Wnt signaling regulation by β-catenin sequestration might not be limited to classical cadherins. Although it was generally accepted that all Pcdhs lack a β-catenin binding site, small serine-rich domains homologous to the β-catenin binding site of classical cadherins have been identified in the C-terminus of Pcdh7 and Pcdh11Y ([@B28]; [@B275]; [@B209]). Furthermore, mass spectrometric analysis provided direct evidence for a physical interaction between γ-Pcdhs and α- and β-catenin ([@B79]).

Even without a β-catenin binding site, Pcdhs can affect the ratio of nuclear versus cytoplasmic β-catenin. *PCDH18* knockdown in a human colon mucosal epithelial cell line promotes the nuclear accumulation of β-catenin and LEF/TCF transcriptional activity, while the overexpression of PCDH10, PCDH20, or PCDHGA9 in RPMI-8226, CNE1, or SGC-7901 cells, respectively, promotes the translocation of β-catenin from the nucleus to the cytoplasm and its accumulation at the membrane, thereby decreasing LEF/TCF activity ([@B29]; [@B272]; [@B295]; [@B264]). The observed negative relationship between the expression of several Pcdhs and the nuclear accumulation of β-catenin contradicts findings describing increased Wnt signaling and TCF/LEF activity due to nuclear accumulation of β-catenin with PCDH11Y overexpression in human prostate cancer cells (LNCaP) ([@B275]). This discrepancy might be related to the proto-oncogenic role of Pcdh11Y.

The mechanisms by which translocation and accumulation occurs in Pcdhs lacking a β-catenin binding site are currently unknown. Perhaps they could indirectly sequester β-catenin through a common binding partner, and regulate the release and translocation of β-catenin via phosphorylation events or ICD cleavage. One cPcdh (PCDHGC3) was found to modulate Wnt signaling by directly binding the scaffold protein Axin1 at the cell membrane ([@B160]). Thus, sequestration of Wnt signaling molecules at the plasma membrane might be common within the Pcdh family. PCDHGC3 was found to compete with Disheveled to bind the DIX domain of Axin1, resulting in its stabilization, reduced phosphorylation of LRP6 and a decrease of Wnt signaling in luciferase TOP FLASH assays ([@B160]) ([Figure 7A](#F7){ref-type="fig"}). Intriguingly, none of the other PCDHGs can bind Axin1. In contrast, individual overexpression of other PCDHG isoforms (PCDHGA1, PCDHGA3, PCDHGA7-10, PCDHGB1-7 and PCDHGC5) was observed to significantly increase β-catenin/TCF transcriptional activity ([@B160]). Similar to *in vitro* models, *in vivo* overexpression of PCDHGA1- or PCDHGC3-mCherry in Emx1-positive cells in the murine cerebral cortex significantly increased and decreased reporter activity, respectively ([@B160]). These findings further support the hypothesized Pcdh-subtype dependent nature of the effects of Pcdh expression on Wnt signaling.

The intracellular availability of β-catenin can also be directly regulated by its degradation in the cytoplasm. Multiple studies link the overexpression or silencing of ncPcdhs (PCDH8, PCDH10, PCDH18, PCDH20) in primary tumors and tumor cell lines to reduced or increased levels of phosphorylated GSK3β, respectively ([@B156]; [@B272]; [@B295]; [@B298]). These changes in phosphorylated GSK3β levels were accompanied by altered β-catenin levels and expression of Wnt target genes ([Figure 7B](#F7){ref-type="fig"}) ([@B156]; [@B272]; [@B295]; [@B298]). Pcdhs could also modulate the activity of kinases and phosphatases that play a role in Wnt signaling. For instance, signaling downstream of Fak and Pyk2 has been linked to several Wnt pathway modules ([@B28]; [@B61], [@B62]; [@B233]; [@B293]).

Finally, some Pcdhs might regulate the expression of nuclear β-catenin importers/exporters. One study described a strongly reduced expression of *BCL9* when PCDH10 was overexpressed in RPMI-8226 and KM3 cells ([@B272]). BCL9 is a necessary transcriptional co-activator of Wnt target genes, and a complex of BCL9 and Pygopus has been shown to recruit β-catenin to the nuclear compartment ([Figure 7C](#F7){ref-type="fig"}) ([@B124]; [@B244]).

### Pcdh and Non-canonical Wnt Signaling {#S4.SS6.SSS2}

One of the best characterized Pcdh/Wnt interactions is the activation of the Wnt/Planar Cell Polarity (PCP) pathway by Pcdh8 to regulate convergent extension and tissue separation/morphogenesis during *Xenopus laevis* gastrulation ([Figure 8](#F8){ref-type="fig"}). In the vertebrate Wnt/PCP pathway, binding of Wnt ligands to Frizzled (Fz) receptors recruits Disheveled (Dvl) to the membrane, resulting in the formation of complexes with either Disheveled-associated activator of morphogenesis 1 (Daam1) or small GTPase Rac1 that activate downstream signaling via RhoA or c-jun N-terminal kinase (JNK), respectively ([@B230]; [@B5]; [@B16]; [@B257]; [@B77], [@B76]; [@B161]). The extracellular domain of Pcdh8 is able to directly bind Frizzled7 to coordinate cellular polarity ([@B166]; [@B249]; [@B123]). Both components are necessary for the initiation of Wnt/PCP signaling, as loss of Pcdh8 function was found to specifically block JNK activation via Rac1 ([@B249]). Furthermore, four intracellular Pcdh8 interaction partners related to the Wnt/PCP-associated molecular network have been recently discovered. The intracellular domain of Pcdh8 can sequester Sprouty to inhibit its antagonistic effect on Wnt/PCP signaling ([@B263]). Moreover, a direct physical interaction between *Xenopus* (x)ANR5 and Pcdh8 can activate the downstream effector molecules JNK and Rho, strengthening the output of the PCP pathway ([@B36]), while the interaction between Pcdh8 and Nemo-like Kinase1 (NLK1) is necessary for the stabilization of Pcdh8 ([@B128]). Lastly, an interaction with casein kinase 2β (CK2β) blocks CK2β-mediated stabilization of β-catenin, thereby reducing canonical Wnt/β-catenin signaling ([@B116]). Expression of Pcdh8 itself is regulated by Wnt/PCP signaling, providing a feedback loop into this pathway ([@B216]).

![The role of Pcdh8 in Wnt/PCP signaling in Xenopus. The extracellular domain of Pcdh8 can bind Frizzled, and thus initiate the Wnt/PCP pathway. Pcdh8 sequesters Sprouty (Spr), thereby inhibiting its antagonizing effect on the Wnt/PCP pathway. In addition, Pcdh8-ANR5 interaction directly activates the effector molecules RhoA and JNK. The interaction with Nemo-like kinase 1 (NLK1) stabilizes Pcdh8, thereby ensuring continued Wnt/PCP pathway activation. Finally, the interaction with CK2β blocks a stabilizing phosphorylation of β-catenin, and ultimately results in decreased canonical Wnt signaling.](fnmol-13-00117-g008){#F8}

In summary, although the majority of Pcdhs do not possess a β-catenin binding site, the interplay between cadherin-mediated adhesion and Wnt signaling seems to be conserved across the cadherin superfamily. Identifying a general interaction modality between Pcdh- and Wnt-mediated signaling pathways might prove difficult, as available evidence highlights Pcdh- and context-dependent effects on Wnt signaling. Clearly, additional research is required to better understand the complex relationship between individual Pcdhs and Wnt-related pathways. Moreover, since most studies so far have been performed in cancer cells, whether and how their findings might translate contextually to neural development is currently poorly understood. The comprehensive investigation of binding partners and molecular action mechanisms of individual Pcdhs will therefore be a crucial step in the complete elucidation of Pcdh functions across multiple contexts.

Pyk2 and FAK Link Three Distinct Pcdh-Elicited Signaling Pathways {#S4.SS7}
-----------------------------------------------------------------

Signaling downstream of Pcdhs has been shown to also involve the Pyk2/FAK/WRC pathway. However, so far no studies have directly connected Pyk2/FAK/Wnt with Pcdh-mediated signaling, although Pyk2 and FAK are known Wnt pathway inducers. VEGF-activated FAK can directly phosphorylate β-catenin to promote Wnt signaling ([@B34]). Moreover, active Pyk2 and FAK can phosphorylate GSK3β, ultimately resulting in the degradation of GSK3β and the accumulation of β-catenin, leading to increased Wnt signaling. In addition, active Pyk2 can also phosphorylate β-catenin ([@B61], [@B62]). CPcdhs regulate WRC activity by binding to Pyk2 and FAK, hence preventing their autophosphorylation and subsequent activation. Therefore, Pyk2 and FAK could represent a link between the Pcdh-regulated Wnt and WRC signaling pathways ([Figure 9](#F9){ref-type="fig"}). Pyk2 generally acts as an oncogene, although in some cases it can function as a tumor suppressor by inducing apoptosis \[reviewed in [@B223]\].

![Pyk2 is a hub molecule connecting three signaling pathways modulated by Pcdhs. In cancer, silencing of Pcdhs could promote FAK/Pyk2 activation, thereby inhibiting GSK3β and activating Wnt signaling. Upon γ-Pcdh loss, Pyk2 accumulation and binding to PDCD10 elicits neuronal apoptosis. Rac1 activation and subsequent WRC complex activation is inhibited upon α- and γ-Pcdh loss due to autophosphorylation of Pyk2.](fnmol-13-00117-g009){#F9}

Pyk2 has also been linked to neuronal apoptosis elicited by the absence of γ-Pcdhs. γ-Pcdh ICD negatively regulates Pyk2, preventing its autophosphorylation and Pyk2 accumulation in the cells leading to their death. Moreover, Pyk2 can interact with PDCD10 to induce apoptosis. Furthermore, γ-Pcdh ICD depletion elicits apoptosis caused by PDCD10 accumulation ([@B27]; [@B146]). Therefore, Pyk2 might represent a node connecting Wnt, WRC, and apoptotic molecular networks ([Figure 9](#F9){ref-type="fig"}).

Conclusion {#S5}
==========

Protocadherins play multiple roles during development, in adulthood, and in pathogenesis. In different processes the same Pcdhs can mediate opposite functions, highlighting the impact of context on Pcdh action. On a cellular-molecular level, context determines whether specific Pcdhs are expressed, inserted in the membrane, proteolytically processed, or intracellularly trafficked; in addition, it influences the availability of Pcdh interaction partners that allow the initiation of diverse cellular processes. This review aimed to provide an overview of Pcdh-driven molecular interactions and downstream signaling pathways identified within different contexts in order to identify general mechanisms of Pcdh action. In this last section, we describe major conclusions that can be derived from this survey, and potential topics for future research.

Overall, regulation of Pcdh cell surface expression is of central importance in several neurobiological processes, such as neuronal recognition or neural cell survival. In this context, the identity of Pcdhs involved in cell-cell interactions seems to particularly matter, as for instance PcdhγC4 was identified as a neuronal pro-survival isoform within the γ-Pcdh cluster ([@B64]).

It is clear that Pcdhs are subject to proteolytic cleavage, but this process has not been systematically characterized across this protein family. Moreover, more research into the nuclear binding partners of the ICD is necessary to identify the action mechanism of Pcdhs at the nucleus and potentially directly regulated target genes. Furthermore, evidence points toward a significant endosomal recycling of Pcdhs. The extent of the influence endocytosis might have on Pcdh-mediated functions, and the Pcdh signaling modules that could be active at the endosomal level, rather than the cell membrane, are virtually unknown.

Most current knowledge on the interactions between Pcdhs and other proteins, including other Pcdhs, describes molecular mechanisms and binding dynamics at the extracellular level. Thus, many mechanistic questions regarding the interaction between intracellular proteins and the Pcdh ICD remain to be addressed. As discussed above, Pyk2 and FAK could interconnect three different Pcdh-modulated signaling pathways. Recently the PI3K-AKT pathway was shown to be involved in Pcdh-mediated neuronal survival ([@B22]). The interplay between this pathway and Pyk2 was demonstrated in several cancer types (reviewed in [@B223]). Thus, Pyk2 might connect an even larger number of Pcdh-induced signaling networks. Downstream signaling through the ICD has been mostly analyzed in cancer. Despite fundamental contextual differences, interesting Pcdh-related molecular network commonalities can be identified between oncogenesis and neural development/function. Therefore, by comprehensively examining knowledge from both fields, it might be possible to gather novel insights regarding Pcdh downstream signaling pathways.

Evolutionary studies have indicated the presence of conserved motifs within the Pcdh ICD; however, their contribution to Pcdh function is not yet fully understood ([@B100]). Interesting to remark is that recent discoveries of independent Pcdh family expansions in animal classes evolutionarily distant from mammals, such as the Cephalopods ([@B2]; [@B231]), might shed a completely novel light on Pcdh-related roles and action mechanisms, including signaling through the ICD in neural development.

Wnt and WRC pathway components have been shown to be very important mediators of Pcdh-driven functions both in brain development and in cancer. Pcdh depletion has been shown to result in neurodevelopmental defects due to a dysregulation of WRC signaling. Both cPcdhs and ncPcdhs regulate the WRC positively through the recruitment of GTPases in several contexts. Interestingly, no study has linked the WRC pathway to δ1-Pcdh functions yet. However, much less is currently known about how the absence of Pcdhs in many cancers affects WRC signaling and cytoskeletal remodeling. A hypothesis that remains to be further investigated is that increased activity of the WRC might enhance cancer cell motility, and thus malignancy.

In conclusion, the elucidation of the exact molecular mechanisms underlying the translation of Pcdh-elicited signals to the cellular machinery, as well as the components of those signaling cascades, might represent interesting and important avenues for future biomedical research. Research efforts in this direction are bound to not only increase our understanding of the mechanisms such as governing brain formation and function, but also reveal the molecular etiology of cancer.
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